Organization · Venture Capital
OCCIDENT
OCCIDENT is a venture capital firm based in Munich, Germany, and Zug, Switzerland, specializing in deep-tech startups, particularly those originating from scientific research. The firm invests at the seed stage and focuses on sectors such as life sciences and industrial tech.
Overview
What OCCIDENT does
What OCCIDENT is
OCCIDENT is a venture capital firm based in Munich, Germany, and Zug, Switzerland, specializing in deep-tech startups, particularly those originating from scientific research. The firm invests at the seed stage and focuses on sectors such as life sciences and industrial tech.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2012
- Approximate age
- About 14 years
- Structured capabilities
- Funder
- Last reviewed
- May 3, 2026
Official channels
Find OCCIDENT elsewhere
Open the official website or a supported primary organization account.
Capability profile
OCCIDENT as a funder
Investment thesis
OCCIDENT is 'The Science Investor,' focusing on deep-tech startups, particularly spin-offs from scientific research, to create tangible societal impact.
Focus narrative
OCCIDENT invests primarily at the seed financing stage in deep-tech startups. The organization collaborates closely with founding teams to support their endeavors, ensuring that investments are aligned with sustainable success potential.
Value beyond capital
OCCIDENT adds value to its portfolio companies by providing not only capital but also strategic support and guidance, leveraging its expertise in deep-tech and scientific research to help startups navigate challenges and achieve sustainable growth.
Focus and fit
- Stages
- Seed · Seed+
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 16
- Recorded notable exits
- Tubulis
Portfolio context
Lymphatica: A medtech company developing an implantable device for lymphedema treatment. Altavo: A startup creating non-invasive technology for artificial voices for cancer patients. Chipmetrics: A company specializing in innovative measurement chips for the semiconductor industry. ReCatalyst: A spin-off developing catalysts for fuel cells to optimize platinum use. EBAMed: Focused on monitoring heart movements during cardiac radioablation. core sensing: Develops smart integrated sensors for machinery. Avelo: A diagnostics startup improving tuberculosis diagnosis with a breath collector. hemotune: Innovates blood purification using magnetic nanoparticles. Tubulis: Develops antibody-drug conjugates targeting disease mechanisms.
Common questions
What to know about OCCIDENT
Upseed classifies OCCIDENT under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 3, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.